April 20, 2021

Govt locations second buy order with SII for 1 crore doses of Covishield



New Delhi: The Centre on Wednesday positioned a second buy order with the Serum Institute of India for the availability of 1 crore doses of Oxford-AstraZeneca COVID-19 vaccine ‘Covishield‘, every costing Rs 210, together with GST, sources mentioned.

The HLL Lifecare, a public sector enterprise, on behalf of the Union well being ministry issued the availability order within the identify of Prakash Kumar Singh, Director, Authorities and Regulatory Affairs at Serum Institute of India (SII), Pune.

The federal government had on January 11 positioned an order for 1.1 crore doses of Covishield at a value of Rs 231 crore, which has now risen to Rs 441 crore with the second order positioned on Wednesday, a supply mentioned.

The federal government had on January 11 additionally dedicated to purchase from the Serum Institute 4.5 crore doses of the vaccine, along with the primary order of 1.1 crore doses.

India has authorized two COVID-19 vaccines–Covishield manufactured by SII and indigenously developed Covaxin of Bharat Biotech–for restricted emergency use within the nation.